# LAMA2

## Overview
The LAMA2 gene encodes the laminin subunit alpha 2, a vital component of the extracellular matrix protein family known as laminins. Laminins are heterotrimeric glycoproteins composed of alpha, beta, and gamma chains, and they play a crucial role in the structural integrity and function of basement membranes. Specifically, laminin subunit alpha 2 is a part of the laminin-211 and laminin-221 isoforms, which are predominantly found in the basement membrane of skeletal muscle fibers. This protein is essential for linking the muscle cell membrane to the extracellular matrix, thereby maintaining muscle fiber stability and facilitating signal transduction. Mutations in the LAMA2 gene can lead to congenital muscular dystrophies, highlighting its significance in muscle development and maintenance (BarrazaFlores2020Laminin; Miner2008Laminins).

## Structure
The LAMA2 gene encodes the laminin-α2 protein, a crucial component of the laminin-211 and laminin-221 isoforms in skeletal muscle. The primary structure of laminin-α2 includes a signal peptide and multiple domains, such as the N-terminal domain and laminin G-like (LG) domains (BarrazaFlores2020Laminin). The protein is composed of a 300-kDa N-terminal fragment and an 80-kDa C-terminal fragment. The N-terminal domain is responsible for nucleating associations with other laminin chains and components of the muscle basal lamina, such as collagen IV and heparan sulfate proteoglycans (BarrazaFlores2020Laminin).

The secondary structure of laminin-α2 features alpha-helices and beta-sheets, with the G domain predominantly consisting of beta-sheets and containing conserved cysteine and glycine residues (Engvall1996Domains). The tertiary structure involves the folding of these domains, while the quaternary structure refers to the assembly with beta and gamma chains to form a heterotrimeric protein complex (Miner2008Laminins).

The C-terminal domain contains five LG domains, which are important for binding to cell receptors, predominantly integrin-α7β1 and the dystroglycan protein complex (BarrazaFlores2020Laminin). Post-translational modifications may include glycosylation, which is common in extracellular matrix proteins (Miner2008Laminins). Splice variants can result in different isoforms with distinct functions (Miner2008Laminins).

## Function
The LAMA2 gene encodes the laminin subunit alpha 2, a critical component of the laminin-2 complex, which plays a significant role in maintaining the structural integrity of muscle tissue. In healthy human cells, laminin alpha 2 is prominently expressed in the basement membrane of skeletal muscle fibers, where it links the sarcolemma to the basement membrane and the underlying cytoskeleton. This linkage is crucial for muscle fiber stability during contraction, as it helps transmit force between muscle fibers and prevents muscle cell detachment and damage (Mcgowan2000Laminins; Miner2008Laminins).

Laminin alpha 2 is also involved in the organization and function of neuromuscular junctions (NMJs), where it contributes to the structural framework and signaling pathways necessary for muscle cell adhesion, survival, and repair (Schéele2007Laminin; BarrazaFlores2020Laminin). In the nervous system, laminin alpha 2 supports Schwann cell proliferation and myelination, which are essential for proper nerve function and regeneration (Miner2004LAMININ; Previtali2020LAMA2). The protein's interactions with receptors such as integrins and dystroglycan are vital for these processes, influencing cell adhesion, differentiation, and signaling (Schéele2007Laminin; Ahmed2019Laminin).

## Clinical Significance
Mutations in the LAMA2 gene, which encodes the laminin subunit alpha 2, are primarily associated with congenital muscular dystrophy type 1A (MDC1A), also known as merosin-deficient congenital muscular dystrophy. This condition is characterized by severe muscle weakness, hypotonia, and developmental delays, often presenting at birth or within the first few months of life (Enzmann2024A; Muntoni2004The). The absence or significant reduction of laminin-α2 chain expression leads to early-onset symptoms, including skeletal deformities, non-ambulation, and respiratory insufficiency (Tran2023Merosindeficient).

LAMA2-related muscular dystrophy (LAMA2-RD) can manifest in two main forms: a severe congenital form and a milder limb-girdle-type phenotype. The congenital form is associated with complete merosin deficiency, while the milder form may involve partial merosin deficiency, leading to less severe symptoms such as proximal muscle weakness and scoliosis (Sarkozy2020LAMA2-Related; Enzmann2024A). Central nervous system involvement, including white matter changes and seizures, is also observed in some patients (Tan2021Natural; Muntoni2004The).

Genetic testing is recommended for accurate diagnosis, as clinical manifestations can vary widely, and certain mutations are associated with more severe disease courses (Geranmayeh2010Genotype–phenotype).

## Interactions
The LAMA2 gene encodes the laminin α2 chain, which is a crucial component of the laminin-211 and laminin-221 isoforms. These isoforms are integral to the basement membrane in skeletal muscle and interact with several key proteins to maintain muscle integrity. Laminin α2 binds to the dystroglycan complex (DGC) and integrin α7β1, facilitating the connection between the basal lamina and muscle cell cytoskeleton. This interaction is essential for mechanical support during muscle contraction and for stabilizing the sarcolemma (BarrazaFlores2020Laminin).

Mutations in LAMA2 disrupt these interactions, leading to muscular dystrophy. The dystroglycan binds specifically to the G domain of laminin α2, while integrin α7β1 interacts at myotendinous junctions, playing a critical role in muscle regeneration and repair (BarrazaFlores2020Laminin; Miner2008Laminins). In the nervous system, laminin α2 is involved in neuromuscular junction organization, and its absence can lead to defective synapses (Miner2008Laminins).

Research has explored the use of engineered linker proteins, such as αLNNd and miniagrin, to restore these interactions in LAMA2-related muscular dystrophy. These proteins enhance basement membrane assembly by promoting laminin polymerization and receptor binding, compensating for the loss of laminin α2 (Yurchenco2019Linker; Reinhard2017Linker).


## References


[1. (Reinhard2017Linker) Judith R. Reinhard, Shuo Lin, Karen K. McKee, Sarina Meinen, Stephanie C. Crosson, Maurizio Sury, Samantha Hobbs, Geraldine Maier, Peter D. Yurchenco, and Markus A. Rüegg. Linker proteins restore basement membrane and correct lama2 -related muscular dystrophy in mice. Science Translational Medicine, June 2017. URL: http://dx.doi.org/10.1126/scitranslmed.aal4649, doi:10.1126/scitranslmed.aal4649. This article has 59 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/scitranslmed.aal4649)

[2. (Schéele2007Laminin) Susanne Schéele, Alexander Nyström, Madeleine Durbeej, Jan F. Talts, Marja Ekblom, and Peter Ekblom. Laminin isoforms in development and disease. Journal of Molecular Medicine, 85(8):825–836, April 2007. URL: http://dx.doi.org/10.1007/s00109-007-0182-5, doi:10.1007/s00109-007-0182-5. This article has 112 citations.](https://doi.org/10.1007/s00109-007-0182-5)

[3. (Yurchenco2019Linker) Peter D. Yurchenco and Karen K. McKee. Linker protein repair of lama2 dystrophic neuromuscular basement membranes. Frontiers in Molecular Neuroscience, December 2019. URL: http://dx.doi.org/10.3389/fnmol.2019.00305, doi:10.3389/fnmol.2019.00305. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2019.00305)

[4. (Miner2004LAMININ) Jeffrey H. Miner and Peter D. Yurchenco. Laminin functions in tissue morphogenesis. Annual Review of Cell and Developmental Biology, 20(1):255–284, November 2004. URL: http://dx.doi.org/10.1146/annurev.cellbio.20.010403.094555, doi:10.1146/annurev.cellbio.20.010403.094555. This article has 590 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1146/annurev.cellbio.20.010403.094555)

[5. (Ahmed2019Laminin) Maqsood Ahmed, Leandro N. Marziali, Ernest Arenas, M. Laura Feltri, and Charles ffrench-Constant. Laminin α2 controls mouse and human stem cell behaviour during midbrain dopaminergic neuron development. Development, January 2019. URL: http://dx.doi.org/10.1242/dev.172668, doi:10.1242/dev.172668. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.172668)

[6. (Tran2023Merosindeficient) Van Khanh Tran, Ngoc-Lan Nguyen, Lan Ngoc Thi Tran, Phuong Thi Le, Anh Hai Tran, Tuan L. A. Pham, Nguyen Thi Kim Lien, Nguyen Thi Xuan, Le Tat Thanh, Thanh Van Ta, Thinh Huy Tran, and Huy-Hoang Nguyen. Merosin-deficient congenital muscular dystrophy type 1a: detection of lama2 variants in vietnamese patients. Frontiers in Genetics, June 2023. URL: http://dx.doi.org/10.3389/fgene.2023.1183663, doi:10.3389/fgene.2023.1183663. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2023.1183663)

[7. (Muntoni2004The) Francesco Muntoni and Thomas Voit. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscular Disorders, 14(10):635–649, October 2004. URL: http://dx.doi.org/10.1016/j.nmd.2004.06.009, doi:10.1016/j.nmd.2004.06.009. This article has 214 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.nmd.2004.06.009)

[8. (Tan2021Natural) Dandan Tan, Lin Ge, Yanbin Fan, Xingzhi Chang, Shuang Wang, Cuijie Wei, Juan Ding, Aijie Liu, Shuo Wang, Xueying Li, Kai Gao, Haipo Yang, Chengli Que, Zhen Huang, Chunde Li, Ying Zhu, Bing Mao, Bo Jin, Ying Hua, Xiaoli Zhang, Bingbing Zhang, Wenhua Zhu, Cheng Zhang, Yanjuan Wang, Yun Yuan, Yuwu Jiang, Anne Rutkowski, Carsten G. Bönnemann, Xiru Wu, and Hui Xiong. Natural history and genetic study of lama2-related muscular dystrophy in a large chinese cohort. Orphanet Journal of Rare Diseases, July 2021. URL: http://dx.doi.org/10.1186/s13023-021-01950-x, doi:10.1186/s13023-021-01950-x. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13023-021-01950-x)

[9. (BarrazaFlores2020Laminin) Pamela Barraza-Flores, Christina R. Bates, Ariany Oliveira-Santos, and Dean J. Burkin. Laminin and integrin in lama2-related congenital muscular dystrophy: from disease to therapeutics. Frontiers in Molecular Neuroscience, February 2020. URL: http://dx.doi.org/10.3389/fnmol.2020.00001, doi:10.3389/fnmol.2020.00001. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2020.00001)

[10. (Sarkozy2020LAMA2-Related) Anna Sarkozy, A. Reghan Foley, Alberto A. Zambon, Carsten G. Bönnemann, and Francesco Muntoni. Lama2-related dystrophies: clinical phenotypes, disease biomarkers, and clinical trial readiness. Frontiers in Molecular Neuroscience, August 2020. URL: http://dx.doi.org/10.3389/fnmol.2020.00123, doi:10.3389/fnmol.2020.00123. This article has 59 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2020.00123)

[11. (Miner2008Laminins) Jeffrey H. Miner. Laminins and their roles in mammals. Microscopy Research and Technique, 71(5):349–356, January 2008. URL: http://dx.doi.org/10.1002/jemt.20563, doi:10.1002/jemt.20563. This article has 132 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jemt.20563)

[12. (Enzmann2024A) Cornelia Enzmann, Leonie Steiner, Katarzyna Pospieszny, Christiane Zweier, Kevin Plattner, Dominique Baumann, Bettina Henzi, Elea Galiart, Mirjam Fink, David Jacquier, Georg M. Stettner, Paolo Ripellino, Joel Fluss, and Andrea Klein. A multicenter cross-sectional study of the swiss cohort of lama2-related muscular dystrophy. Journal of Neuromuscular Diseases, 11(5):1021–1033, September 2024. URL: http://dx.doi.org/10.3233/jnd-240023, doi:10.3233/jnd-240023. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3233/jnd-240023)

[13. (Geranmayeh2010Genotype–phenotype) Fatemeh Geranmayeh, Emma Clement, Lucy H Feng, Caroline Sewry, Judith Pagan, Rachael Mein, Stephen Abbs, Louise Brueton, Anne-Marie Childs, Heinz Jungbluth, Christian G De Goede, Bryan Lynch, Jean-Pierre Lin, Gabriel Chow, Carlos de Sousa, Olivia O’Mahony, Anirban Majumdar, Volker Straub, Katherine Bushby, and Francesco Muntoni. Genotype–phenotype correlation in a large population of muscular dystrophy patients with lama2 mutations. Neuromuscular Disorders, 20(4):241–250, April 2010. URL: http://dx.doi.org/10.1016/j.nmd.2010.02.001, doi:10.1016/j.nmd.2010.02.001. This article has 150 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.nmd.2010.02.001)

[14. (Mcgowan2000Laminins) Kelly Ann Mcgowan and M. Peter Marinkovich. Laminins and human disease. Microscopy Research and Technique, 51(3):262–279, 2000. URL: http://dx.doi.org/10.1002/1097-0029(20001101)51:3<262::AID-JEMT6>3.0.CO;2-V, doi:10.1002/1097-0029(20001101)51:3<262::aid-jemt6>3.0.co;2-v. This article has 95 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/1097-0029(20001101)51:3)

[15. (Previtali2020LAMA2) Stefano Carlo Previtali and Alberto Andrea Zambon. Lama2 neuropathies: human findings and pathomechanisms from mouse models. Frontiers in Molecular Neuroscience, April 2020. URL: http://dx.doi.org/10.3389/fnmol.2020.00060, doi:10.3389/fnmol.2020.00060. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2020.00060)

[16. (Engvall1996Domains) Eva Engvall and Ulia M. Wewer. Domains of laminin. Journal of Cellular Biochemistry, 61(4):493–501, June 1996. URL: http://dx.doi.org/10.1002/(SICI)1097-4644(19960616)61:4<493::AID-JCB2>3.0.CO;2-J, doi:10.1002/(sici)1097-4644(19960616)61:4<493::aid-jcb2>3.0.co;2-j. This article has 197 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/(SICI)1097-4644(19960616)61:4)